Spasticity / Movement Disorders

Research Study

Outcomes Of Week-24 Completers and Subjects Who Had Follow-Up Beyond Week 24 After a Single Treatment of DaxibotulinumtoxinA for Injection (RT002): Results of a Phase 2, Open-Label, Dose Escalating Study In Isolated Cervical Dystonia

Thursday, February 15
5:10 PM - 5:25 PM
Room: Chicago A

Send Email for Atul Patel


Assets

Outcomes Of Week-24 Completers and Subjects Who Had Follow-Up Beyond Week 24 After a Single Treatment of DaxibotulinumtoxinA for Injection (RT002): Results of a Phase 2, Open-Label, Dose Escalating Study In Isolated Cervical Dystonia



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Outcomes Of Week-24 Completers and Subjects Who Had Follow-Up Beyond Week 24 After a Single Treatment of DaxibotulinumtoxinA for Injection (RT002): Results of a Phase 2, Open-Label, Dose Escalating Study In Isolated Cervical Dystonia